Last edition
News about "Pharma Patent "
FTC Tracks Pharma Strategies as Patent Cliff Approaches
The US Federal Trade Commission (FTC) is keeping a close watch on how pharmaceutical companies respond as several blockbuster drugs approach the end of their patent life. The regulator is particularly concerned about practices that could delay the entry of lower-cost generic medicines.
Pharma Patent | 18/03/2026 | By Darshana
Biocon & Mylan Win Patent Litigation Asserted by Sanofi for Insulin Glargine Device
Biocon Ltd.announced today that it has won a U.S. court ruling that invalidated a Sanofi patent on the Insulin Glargine device , removing a key legal hurdle to commercializing Semglee® (Insulin Glargine) co-developed with Mylan, in the U.S.
Pharma Patent | 15/03/2020 | By Darshana | 301
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy